Skip to main content
Log in

New insight into the management of IgA nephropathy

  • Letter to the editor
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lv J, Zhang H, Wong MG, et al; TESTING Study Group. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA 2017;318(5): 432–42.

    Article  CAS  Google Scholar 

  2. Rauen T, Eitner F, Fitzner C, et al. STOP-IgAN investigators. Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med. 2015;373:2225–36.

    Article  CAS  Google Scholar 

  3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013; 3(Suppl):1–150.

    Google Scholar 

  4. Yang M, Xu G, Ling L, et al. Performance of the creatinine and cystatin C-based equations for estimation of GFR in Chinese patients with chronic kidney disease. Clin Exp Nephrol. 2017;21(2):236–46.

    Article  CAS  Google Scholar 

  5. Bökenkamp A, Laarman CA, Braam KI, et al. Effect of corticosteroid therapy on low-molecular weight protein markers of kidney function. Clin Chem. 2007;53(12):2219–21.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from Chinese Society of Nephrology (14050430580).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xin Du.

Ethics declarations

Conflict of interest

No potential conflict of interest relevant to this letter was reported.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zou, Y., Yang, M. & Du, X. New insight into the management of IgA nephropathy. Clin Exp Nephrol 22, 1442–1443 (2018). https://doi.org/10.1007/s10157-018-1555-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-018-1555-5

Navigation